Evidence map›Paper›PMID 38334608›Full record

ArticleCells2024

SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma.

Seung-Hyun Bae, Kyung Yong Lee, Suji Han, Chul Won Yun, ChanHyeok Park, Hyonchol Jang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Seung-Hyun BaeDivision of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0002-6593-0036
Kyung Yong LeeDepartment of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.ORCID 0000-0003-2701-0762
Suji HanDivision of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0002-5460-7786
Chul Won YunDivision of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.
ChanHyeok ParkDivision of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Hyonchol JangDivision of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0003-1436-457X
National Cancer Center · KR

Funding

National Cancer Center 2010272National Cancer Center 2110110National Cancer Center 2210350National Research Foundation of Korea 2017R1A2B4009200National Research Foundation of Korea 2021R1F1A106316313National Research Foundation of Korea 2022R1A2C2009720National Research Foundation of Korea 2022R1A5A102641311
6 · The paper itself

Abstract

Effectively targeting cancer stemness is essential for successful cancer therapy. Recent studies have revealed that

Indexed as

Adenocarcinoma of LungLung NeoplasmsNeoplastic Stem CellsSOXB1 Transcription FactorsHumansRNA, Small InterferingRNA, Small InterferingSOX2 protein, humanSOXB1 Transcription Factorscancer stem cell-like propertiesCRISPR/Cas9lung adenocarcinomashRNASOX2

Identifiers

PMID38334608
PMCPMC10854781
OpenAlexW4391157079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.